Core Viewpoint - Fosun Pharma (02196) plans to adopt a restricted share unit scheme for H shares in 2025, aiming to incentivize employees through equity participation [1] Summary by Relevant Sections Share Grant Details - The company intends to grant a total of 10.6964 million restricted share units to 201 eligible employees upon the adoption of the plan, with the grant date to be determined by the board [1] - The eligible employees can purchase the corresponding number of H shares at a price of RMB 1.00 per share after the restricted share units vest [1] Limitations and Cap - Due to the cap imposed by the Hong Kong Stock Exchange on H share schemes, the maximum number of restricted share units that can be granted under this plan is 13.3705 million, which corresponds to a maximum of 13.3705 million H shares [1] - This represents approximately 0.5007% of the company's total shares and about 2.4716% of the total H shares (excluding treasury shares) [1]

Core Viewpoint - Shanghai Fosun Pharmaceutical Group Co., Ltd. has approved the draft of the 2025 A-share stock option incentive plan to enhance corporate governance and attract talent, aligning the interests of shareholders, the company, and its core team [1][2][5] Group 1: A-share Stock Option Incentive Plan - The board of directors approved the 2025 A-share stock option incentive plan draft and its summary, which aims to establish a long-term incentive mechanism [1][2] - The board's voting results showed unanimous support with 7 votes in favor, 0 against, and 0 abstentions [2][5] - The plan requires approval from the shareholders' meeting to be implemented [2][3] Group 2: Implementation and Management - The board also approved the implementation assessment management measures for the 2025 A-share stock option plan, which will be submitted for shareholder approval [3][4] - The board's voting results for the assessment management measures were also unanimous with 7 votes in favor, 0 against, and 0 abstentions [3][5] Group 3: Authorization for Related Matters - The board proposed to authorize itself to handle matters related to the 2025 A-share option plan, including the number of options and grant dates, subject to shareholder approval [4][5] - The authorization includes necessary actions such as signing grant agreements and applying for registration with relevant authorities [4][7] Group 4: H-share Restricted Stock Unit Plan - The board approved the draft of the 2025 H-share restricted stock unit plan, aimed at further improving corporate governance and retaining talent [5][6] - The plan will also require shareholder approval, and the board will determine the grant date after the plan is adopted [5][6] Group 5: Authorization for H-share Plan - The board proposed to authorize itself to manage matters related to the 2025 H-share restricted stock unit plan, including the number of units granted and the grant date [6][7] - The voting results for this authorization were unanimous with 7 votes in favor, 0 against, and 0 abstentions [6][8]